Journal of clinical psychiatry

• Material Type: 図書
• Title: Journal of clinical psychiatry
• Publication, Distribution, etc.: Physicians Postgraduate Press
• Place of Publication (Country Code): us
• Target Audience: 一般
• Related Material: Chronic major depression : a review and update; https://cir.nii.ac.jp/crid/1130000793719416064; Remission of depression and anxiety : the new goal for patients treated with antidepressants; https://cir.nii.ac.jp/crid/1130000793806808960; Progress with nefazodone; https://cir.nii.ac.jp/crid/1130000793924749440; New pharmacologic options in the treatment of panic disorder; https://cir.nii.ac.jp/crid/1130000794197164288; Risperidone : new horizons for the schizophrenic patient; https://cir.nii.ac.jp/crid/1130000794294608512; Late-life depression : complex problems, new strategies; https://cir.nii.ac.jp/crid/1130000794396513920; Management of persistent anxiety and novel uses for anxiolytics; https://cir.nii.ac.jp/crid/1130000794429273728; Treatment of bipolar disorder; https://cir.nii.ac.jp/crid/1130000794449338880; Restoring harmony-adding life to years : behavioral and psychological symptoms of dementia; https://cir.nii.ac.jp/crid/1130000794457958400; Advances in social phobia; https://cir.nii.ac.jp/crid/1130000794477467264; Functional brain alterations in depression and anxiety; https://cir.nii.ac.jp/crid/1130000794481364480; Recognizing treatment-resistant depression; https://cir.nii.ac.jp/crid/1130000794592770560; Sexual dysfunction associated with depression and its treatment; https://cir.nii.ac.jp/crid/1130000794833794432; Perspectives on Fluvoxamine Therapy; https://cir.nii.ac.jp/crid/1130000794864249728; Augmentation of Antidepressant Medication; https://cir.nii.ac.jp/crid/1130000794965454720; Clinical crossfire : pharmacokinetics and psychiatric drugs; https://cir.nii.ac.jp/crid/1130000795137822848; Early onset of antidepressant action; https://cir.nii.ac.jp/crid/1130000795171465088; Phenomenology and treatment of aggression across psychiatric illnesses; https://cir.nii.ac.jp/crid/1130000795335505024; Depression : new subtypes and therapeutic challenges; https://cir.nii.ac.jp/crid/1130000795424936192; Treatment of depression in long-term care patients; https://cir.nii.ac.jp/crid/1130000795466052352; Managing depression : new perspectives; https://cir.nii.ac.jp/crid/1130000795504486272; The Dynamics of Sex : Gender Differences in Psychiatric Disorders; https://cir.nii.ac.jp/crid/1130000795573672960; Unmasking social phobia in the clinical setting; https://cir.nii.ac.jp/crid/1130000795596585984; The use of newer antipsychotic medications in the elderly; https://cir.nii.ac.jp/crid/1130000795692280960; Focus on panic disorder : antidepressants in practice; https://cir.nii.ac.jp/crid/1130000795693561472; Repairing the shattered self : recovering from trauma; https://cir.nii.ac.jp/crid/1130000795861163648; What makes an antipsychotic atypical?; https://cir.nii.ac.jp/crid/1130000795913990272; The impact of anxiety on the health care system; https://cir.nii.ac.jp/crid/1130000795973726464; Advances in Antidepressant Pharmacotherapy; https://cir.nii.ac.jp/crid/1130000796087903488; Understanding posttraumatic stress disorder; https://cir.nii.ac.jp/crid/1130000796152038656; Antidepressant Discontinuation Syndrome : Update on Serotonin Reuptake Inhibitors; https://cir.nii.ac.jp/crid/1130000796172824832; Focus on depression and anxiety disorders in general medicine; https://cir.nii.ac.jp/crid/1130000796436118912; Antipsychotic agents : clinical, economic, and legal considerations in the treatment of psychosis; https://cir.nii.ac.jp/crid/1130000796664557312; Interaction profile of sertraline with commonly prescribed medications; https://cir.nii.ac.jp/crid/1130000796763165056; Treatment of schizophrenia; https://cir.nii.ac.jp/crid/1130000796792167552; Weight gain : a growing problem in schizophrenia management; https://cir.nii.ac.jp/crid/1130000796861701760; Pharmacology of new antidepressants : from the laboratory to the clinic; https://cir.nii.ac.jp/crid/1130000796885910144; Assessing antidepressant efficasy : a reexamination; https://cir.nii.ac.jp/crid/1130000797032138880; Issues in the clinical use of alprazolam; https://cir.nii.ac.jp/crid/1130000797233489152; Clinical developments in Alzheimer's disease; https://cir.nii.ac.jp/crid/1130000797410502400; Effects of medical interventions on sucidal behavior; https://cir.nii.ac.jp/crid/1130000797481451904; Comparison of the Bioequivalence of Generic versus Branded Clozapine; https://cir.nii.ac.jp/crid/1130000797545815808; The expert consensus guideline series : treatment of schizophrenia 1999; https://cir.nii.ac.jp/crid/1130000797720458752; Alzheimer's Disease : From Research to Practice; https://cir.nii.ac.jp/crid/1130000797747837568; The routine use of atypical antipsychotic agents; https://cir.nii.ac.jp/crid/1130000797772668032; Focus on primary care management of depression; https://cir.nii.ac.jp/crid/1130000797851780864; Management of depression : a successful continuum of care; https://cir.nii.ac.jp/crid/1130000798025603328; Focus on generalized anxiety disorder; https://cir.nii.ac.jp/crid/1130000798144948480; New Uses for Antidepressants; https://cir.nii.ac.jp/crid/1130000798190941568; Treatment of obsessive-compulsive disorder; https://cir.nii.ac.jp/crid/1130000798258829440; Evaluating clinical trial data from schizophrenia research; https://cir.nii.ac.jp/crid/1130000798303234816; Obsessive-Compulsive Disorder : New Perspectives and Practical Management; https://cir.nii.ac.jp/crid/1130282268852745088; Receptor specificity of antidepressants and importance for treatment outcome; https://cir.nii.ac.jp/crid/1130282268955384064; A new concept in the treatment of anxiety; https://cir.nii.ac.jp/crid/1130282269175575680; Neuroimaging assessment of cognitive disorders; https://cir.nii.ac.jp/crid/1130282269271748992; Lithium in the Treatment of Manic-Depressive Illness : An Update; https://cir.nii.ac.jp/crid/1130282269350221440; Managed care and depression : can quality be assured? = Mood and anxiety : disorders in the childbearing years; https://cir.nii.ac.jp/crid/1130282269557003904; Learning from our patients : key issues in the clinical treatment of schizophrenia from a longitudinal perspective; https://cir.nii.ac.jp/crid/1130282269780050944; Antipsychotic drug therapy : current status; https://cir.nii.ac.jp/crid/1130282269869360768; Special challenges and strategies in the treatment of anxiety and mood disorders; https://cir.nii.ac.jp/crid/1130282269900722176; Geropsychiatric advances : new therapies and older patients; https://cir.nii.ac.jp/crid/1130282270072198912; Beyond SSRIs; https://cir.nii.ac.jp/crid/1130282270126203392; Goal of antidepressant therapy : response or remission and recovery?; https://cir.nii.ac.jp/crid/1130282270132642688; Anxiety disorders : the role of serotonin; https://cir.nii.ac.jp/crid/1130282270194770048; The role of anticonvulsants as mood stabilizers; https://cir.nii.ac.jp/crid/1130282270327366144; Optimizing treatment in forms of bipolar disorder; https://cir.nii.ac.jp/crid/1130282270364926720; Clozapine : 1994; https://cir.nii.ac.jp/crid/1130282270514030464; Pharmacoeconomic factors related to the treatment of schizophrenia; https://cir.nii.ac.jp/crid/1130282270729997824; Depressive disorders : advances in clinical management; https://cir.nii.ac.jp/crid/1130282270761129984; Clozapine : a treatment option to be realized; https://cir.nii.ac.jp/crid/1130282270816228224; Optimizing clinical use of SSRIs : theory and practice; https://cir.nii.ac.jp/crid/1130282270826603008; Current Issues in Attention Deficit Disorder; https://cir.nii.ac.jp/crid/1130282270931818240; New strategies for treating alzheimer's disease; https://cir.nii.ac.jp/crid/1130282271087141376; Alzheimer's disease management : algorithmic strategies for diagnosis and treatment; https://cir.nii.ac.jp/crid/1130282271205513216; Depression and anxiety : new tools for diagnosis and treatment; https://cir.nii.ac.jp/crid/1130282271402380416; Social phobia : a comprehensive approach to etiology, diagnosis, and treatment; https://cir.nii.ac.jp/crid/1130282271413602560; The expert consensus guideline series : treatment of posttraumatic stress disorder; https://cir.nii.ac.jp/crid/1130282271502188544; New developments for treating sleep disorders; https://cir.nii.ac.jp/crid/1130282271741680128; The role of enteric-coated fluoxetine once-weekly in achieving optimal outcomes in the long-term treatment of depression; https://cir.nii.ac.jp/crid/1130282271765949952; Focus on transcultural issues in depression and anxiety; https://cir.nii.ac.jp/crid/1130282271775040256; Clinical trial evaluations and outcome measures in psychiatry; https://cir.nii.ac.jp/crid/1130282271778889344; New treatments for anxiety disorders : clinical approaches for successful outcomes; https://cir.nii.ac.jp/crid/1130282271896035712; Treatment-resistant schizophrenia and beyond : current concepts and future prospects; https://cir.nii.ac.jp/crid/1130282271994915200; Psychotic disorders : Many Forms, Common Themes; https://cir.nii.ac.jp/crid/1130282272017480448; Pharmacologic treatment of alcohol abuse and addiction; https://cir.nii.ac.jp/crid/1130282272128640640; New frontiers in OCD spectrum research for psychiatry and primary care; https://cir.nii.ac.jp/crid/1130282272228503936; Focus on social anxiety disorder; https://cir.nii.ac.jp/crid/1130282272333716224; Current issues in drug therapy of depression; https://cir.nii.ac.jp/crid/1130282272384575232; New strategies for treating psychosis; https://cir.nii.ac.jp/crid/1130282272425941632; Time course of improvement in acute mania and rationale for drug selection; https://cir.nii.ac.jp/crid/1130282272468139520; Remission of anxiety-related disorders; https://cir.nii.ac.jp/crid/1130282272478627712; Management of treatment-resistant depression; https://cir.nii.ac.jp/crid/1130282272522110464; Defining remission in generalized anxiety disorder; https://cir.nii.ac.jp/crid/1130282272610698752; Depression : the relevance of the time factor; https://cir.nii.ac.jp/crid/1130282272648549120; Scientific expert meeting: antidepressants in clinical practice; https://cir.nii.ac.jp/crid/1130282272701933824; Weight gain associated with the use of psychotropic medications; https://cir.nii.ac.jp/crid/1130282272748505472; Clinical outcomes in the treatment of schizophrenia; https://cir.nii.ac.jp/crid/1130282272790207104; Olanzapine : positive symptom efficacy and safety; https://cir.nii.ac.jp/crid/1130282272810684416; Pharmacoeconomics of treatment-resistant schizophrenia : proceedings of the national consensus conference on the pharmacoeconomics of treatment-resistant schizophrenia; https://cir.nii.ac.jp/crid/1130282272893286016; Factors to consider in selecting an antidepressant; https://cir.nii.ac.jp/crid/1130282272970564352; Depression and its subtypes : a treatment update; https://cir.nii.ac.jp/crid/1130282272989260032; SPECT imaging in psychiatry : a new look at depression; https://cir.nii.ac.jp/crid/1130282273050049792; Advances in the Management of Chronic Depressive and Anxiety Disorders; https://cir.nii.ac.jp/crid/1130282273088974208; The use of mood stabilizers for treating psychiatric disorders; https://cir.nii.ac.jp/crid/1130282273159417472; Depression and Anxiety; https://cir.nii.ac.jp/crid/1130282273184618624; Patient selection and antidepressant therapy with reboxetine, a new selective norepinephrine reuptake inhibitor; https://cir.nii.ac.jp/crid/1130282273230347776; New development in the treatment of obsessive compulsive disorder; https://cir.nii.ac.jp/crid/1130282273326476928
• Related Material (URI): https://ci.nii.ac.jp/ncid/BA21108020#entity
• Data Provider (Database): 国立情報学研究所 : CiNii Research
• Original Data Provider (Database): CiNii Books; https://ci.nii.ac.jp/books
• NCID: https://ci.nii.ac.jp/ncid/BA21108020 : BA21108020